Mock Ulrike, Mayer Ramona, Potter Richard, Jäger Robert, Vutuc Christian, Eiter Helmut, Hammer Josef, Hawliczek Robert, Hirn Brigitte, Knocke-Abulesz Tomas-Henrik, Kogelnik Hans-Dieter, Lukas Peter, Nechville Elisabeth, Pakisch Brigitte, Papauschek Michael, Ing Raunik Wolfgang, Rhomberg Walter, Sabitzer Hubert, Schratter-Sehn Annemarie, Sedlmayer Felix, Wedrich Irene, Auberger Thomas
Department of Radiotherapy and Radiobiology, Medical University of Vienna, Austria.
Radiother Oncol. 2004 Dec;73 Suppl 2:S29-34. doi: 10.1016/s0167-8140(04)80009-4.
In Austria a national survey was conducted by Med AUSTRON/Osterreichische Gesellschaft for Radio--Onkologie, Radiobiologie und Medizinische Radiophysik (OGRO) in order to estimate the indications, patient numbers and radiotherapy treatment planning procedures and performances at all Austrian radiotherapy institutes. Results were correlated with incidence rates (Austrian cancer registry) to determine patterns of radiotherapy practice in Austria.
At 12 radiotherapy departments of Austria data of all patients receiving irradiation within a 3 months (2002/2003) period were assessed. On the basis of a questionnaire number of treated patients, indications, and parameters of disease (stage, histology) and treatment modalities were evaluated. Results were analysed with regard to different tumour groups, according to academic and non academic hospitals, and correlated with epidemiological data on cancer incidence.
In total, 3783 patients were registered within this period. According to the different tumour entities percentages of patients receiving radiotherapy within initial treatment varied from 3% to 90 % (e.g. brain tumours: 77%, breast cancer: 90%, prostate cancer: 35%). The most frequent indications to radiotherapy per radiotherapy department were breast cancer (range 22%-35%; mean 26%), urological tumours (range 6%-27%; mean 12%) and bone metastases (mean 10%, range 3%-17%).
In Austria breast cancer, urological tumours and bone metastases are representing the most common indications to radiotherapy. Among the different departments variations in indications to radiotherapy were observed. Our study is the first evaluation of radiotherapeutic management in Austria.
在奥地利,Med AUSTRON/奥地利放射肿瘤学、放射生物学和医学放射物理学协会(OGRO)开展了一项全国性调查,以估算奥地利所有放疗机构的放疗适应证、患者数量以及放射治疗计划程序和执行情况。将结果与发病率(奥地利癌症登记处)相关联,以确定奥地利放疗实践模式。
对奥地利12个放疗科室在3个月(2002/2003年)内接受放疗的所有患者的数据进行评估。根据一份调查问卷,对治疗患者数量、适应证、疾病参数(分期、组织学)和治疗方式进行评估。根据不同肿瘤组、学术医院和非学术医院对结果进行分析,并与癌症发病率的流行病学数据相关联。
在此期间共登记了3783例患者。根据不同肿瘤类型,初始治疗时接受放疗的患者百分比从3%到90%不等(例如脑肿瘤:77%,乳腺癌:90%,前列腺癌:35%)。每个放疗科室最常见的放疗适应证是乳腺癌(范围22% - 35%;平均26%)、泌尿系统肿瘤(范围6% - 27%;平均12%)和骨转移瘤(平均10%,范围3% - 17%)。
在奥地利,乳腺癌、泌尿系统肿瘤和骨转移瘤是最常见的放疗适应证。不同科室之间观察到放疗适应证存在差异。我们的研究是对奥地利放射治疗管理的首次评估。